论文部分内容阅读
目的:探讨分析前驱糖尿病诊断中糖化血红蛋白(HbAlc)和空腹血糖(FPC)的临床应用价值。方法:选取我院2012年10月-2013年11月收治的120例前驱糖尿病患者为观察组,同期进行体检的120例健康者作为对照组,分别测定两组人员的HbAlc、FPC的水平,并就结果加以对比分析,探讨其对前驱糖尿病的诊断价值。结果:观察组患者HbAlc为(10.2±3.7)%,FPC为(4.8±0.8)mmol/L,较对照组HbAlc(4.6±0.9)%,FPC(10.3±4.2)mmol/L高,差异均具有统计学意义(p<0.05)。结论:HbAlc和FPC的联合检测在前驱糖尿病的诊断、血糖控制以及治疗效果评价中均具有重要价值。
Objective: To investigate the clinical value of analyzing HbAlc and fasting blood glucose (FPC) in the diagnosis of prediabetes. Methods: One hundred and twenty cases of prediabetes in our hospital from October 2012 to November 2013 were selected as the observation group and 120 healthy subjects were selected as the control group. The levels of HbA1c and FPC in the two groups were measured respectively The results of comparative analysis to explore the diagnosis of prediabetes value. Results: The HbA1c in the observation group was (10.2 ± 3.7)% and the FPC was (4.8 ± 0.8) mmol / L, which was significantly higher than that in the control group (4.6 ± 0.9%) and FPC Statistical significance (p <0.05). Conclusion: The combined detection of HbA1c and FPC is of great value in the diagnosis of diabetes mellitus, glycemic control and evaluation of the therapeutic effect.